Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nestle Sa Cham Et Ve (OP:NSRGF)

97.07 +0.81 (+0.84%)
Streaming Delayed Price Updated: 10:26 AM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nestle Sa Cham Et Ve

Rate Cut Buzz Grows: Are These ETFs Gearing Up For A Fed Pivot?
Amid labor market concerns and potential rate cuts, investors are turning to stable sectors like consumer staples, utilities, and real estate. ETFs like XLP, XLU, and VNQ are gaining interest. 
Via Benzinga
Topics ETFs Economy
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line
Nestle's new Vital Pursuit brand targets individuals on weight-loss drugs without mentioning medications on packaging, addressing regulatory concerns and focusing on marketing through social media. 
Via Benzinga
Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You
Nestlé SA launches Vital Pursuit, a new food line tailored for GLP-1 weight loss medication users, featuring protein, fiber, and essential nutrients. Available Q4 nationwide. 
Via Benzinga
Keurig Dr Pepper Reaffirms Its Guidance, Time to Buy?
Keurig Dr Pepper reported earnings and reaffirmed its guidance, which may cause value-oriented investors to give the stock a closer look 
Via MarketBeat
Magnificent 7 Stocks Become The Star Attractions For Norway's Sovereign Wealth Fund
Norway's sovereign wealth fund has just five equity investments that represent nearly 13% of its total equity allocation. 
Via Benzinga
Is My Candy Bar Getting Smaller? Yes, A Chocolate Crisis Means Smaller, Pricier Hershey's
What does a cocoa shortage mean to the consumer? Either you'll pay more for your chocolate and candy bars, or pack sizes are smaller. Or, both. 
Via Benzinga
Economic Armor: 7 Defensive Consumer Stocks to Weather Any Storm
Although defensive consumer stocks aren’t exactly the sexiest concept ever, brewing troubles could make this space relevant. 
Via InvestorPlace
Arm's IPO Could Be Valued At $54B, Google Slashes Jobs in Global Recruiting, Starbucks Founder And Former CEO To Leave: Today's Top Stories
Financial Times 
Via Benzinga
Topics Initial Public Offering
'Shrinkflation' Shame!: French Supermarket Carrefour Targets PepsiCo, Unilever and Others By Issuing Price Alerts
Carrefour (OTC: CRERF) (OTC: CRRFY) has taken a proactive stance by issuing price alerts on several products as a strategic move to exert pressure on leading consumer goods suppliers such as Nestle... 
Via Benzinga
Topics Supply Chain
Ron DeSantis Escapes Car Accident Unhurt En Route To Campaign Event, TikTok Takes On Twitter, Analysts Expect Nvidia's AI Revenues To Reach $300B In Five Years: Today's Top Stories
The Hill Ron DeSantis Escapes Car Accident Unhurt En Route To Campaign Event 
Via Benzinga
Nestle, Danone Price Rises To Put Them Under France's Inflation Scanner: Report
Product prices of food and beverages manufacturers Nestle S.A.(OTC: NSRGY) (OTC: NSRGF) and Danone (OTC: DANOY) have reportedly risen by more than 10% this year 
Via Benzinga
Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
 
Via Benzinga
Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report
The Justice Department's consumer-protection branch is conducting an investigation into infant formula maker Abbott Laboratories (NYSE: ABT). 
Via Benzinga
SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19
Reuters US Lawmakers Plan Hearing On Kroger, Albertsons' $25B Merger 
Via Benzinga
Consumers Should Be Ready For Further Price Increases, Nestle's Chief Executive Says
Nestle SA's (OTC: NSRGY) (OTC: NSRGF) Chief Executive Officer Mark Schneider said inflation will remain an issue in 2023. 
Via Benzinga
Nestle Bets €40M On Enterome's Preclinical Food Allergy, IBD Hopeful
 
Via Benzinga
Third Largest Player In Baby Formula Jumps In To Ease Shortage In US
Europe's Nestlé SA (OTC: NSRGF) is ramping up hypoallergenic (HA) baby formula production to alleviate the shortage in U.S. supermarkets. 
Via Benzinga
Very Good Food Appoints Former Nestle Executive As Interim CEO
Very Good Food Company Inc (NASDAQ: VGFC) has appointed Matthew Hall as Interim Chief Executive Officer (CEO), effective May 2, 2022. Matt is also joining the... 
Via Benzinga
More Non-US Companies Restricted Services In Russia After US Counterparts
Rio Tinto PLC (NYSE: RIO) became the first leading miner to suspend trading relations with Russian businesses, Reuters reports. Japan's Sony Group (NYSE:... 
Via Benzinga
New Sources of Alternative Proteins Coming in 2022, as Plant-Based Producers Promote New Ideas
FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 11, 2022 – USA News Group – When targeting the US market and heading into 2022, Swiss food giant Nestlé S.A. (OTC:NSRGY)... 
Via FinancialNewsMedia
Dada Nexus, Nestlé Expand Partnership To Boost Omni-Channel Growth
Dada Nexus Ltd (NASDAQ: DADA) and Nestle SA's (OTC: NSRGF) Nestle (China) Co Ltd have expanded their partnership for omnichannel marketing and... 
Via Benzinga
Nestlé Bets $525M On Seres Therapeutics Microbiome Drug For Infectious Diseases
Seres Therapeutics Inc (NASDAQ: MCRB) has inked a $525-million deal with Nestlé Health Science to commercialize SER-109 if it can win FDA approval. SER-109 is an... 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.